[go: up one dir, main page]

FI881104L - Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi - Google Patents

Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi Download PDF

Info

Publication number
FI881104L
FI881104L FI881104A FI881104A FI881104L FI 881104 L FI881104 L FI 881104L FI 881104 A FI881104 A FI 881104A FI 881104 A FI881104 A FI 881104A FI 881104 L FI881104 L FI 881104L
Authority
FI
Finland
Prior art keywords
antidiabetic agents
benzoxazine derivatives
preparing benzoxazine
preparing
derivatives
Prior art date
Application number
FI881104A
Other languages
English (en)
Swedish (sv)
Other versions
FI881104A0 (fi
FI91870B (fi
FI91870C (fi
Inventor
Ikuo Iijima
Masakatsu Ozeki
Kunihito Okumura
Masanori Inamasu
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Publication of FI881104A0 publication Critical patent/FI881104A0/fi
Publication of FI881104L publication Critical patent/FI881104L/fi
Publication of FI91870B publication Critical patent/FI91870B/fi
Application granted granted Critical
Publication of FI91870C publication Critical patent/FI91870C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI881104A 1987-03-18 1988-03-09 Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi FI91870C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6536087 1987-03-18
JP62065360A JPS63230689A (ja) 1987-03-18 1987-03-18 ベンゾオキサジン誘導体

Publications (4)

Publication Number Publication Date
FI881104A0 FI881104A0 (fi) 1988-03-09
FI881104L true FI881104L (fi) 1988-09-19
FI91870B FI91870B (fi) 1994-05-13
FI91870C FI91870C (fi) 1994-08-25

Family

ID=13284716

Family Applications (1)

Application Number Title Priority Date Filing Date
FI881104A FI91870C (fi) 1987-03-18 1988-03-09 Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi

Country Status (16)

Country Link
US (1) US4824833A (fi)
EP (1) EP0283036B1 (fi)
JP (1) JPS63230689A (fi)
KR (1) KR940003071B1 (fi)
CN (1) CN1019911C (fi)
AT (1) ATE67199T1 (fi)
CA (1) CA1305706C (fi)
DE (1) DE3864707D1 (fi)
DK (1) DK147588A (fi)
ES (1) ES2038710T3 (fi)
FI (1) FI91870C (fi)
FR (1) FR2612517B1 (fi)
GR (1) GR3002692T3 (fi)
HU (2) HU203548B (fi)
IE (1) IE60522B1 (fi)
IL (1) IL85768A (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995018805A1 (en) * 1992-09-21 1995-07-13 Senju Pharmaceutical Co., Ltd. 1,4-benzoxazine-2-acetic acid compound, process for producing the same, and use thereof
US5332733A (en) * 1990-11-24 1994-07-26 Kali-Chemie Pharma Gmbh Heterocyclically substituted piperazinoakylbenzoxazine and piperazinoalkylbenzothiazine compounds, processes for preparing them, and medicaments containing them
US5635505A (en) * 1994-01-06 1997-06-03 Senju Pharmaceutical Co., Ltd. 1,4-benzoxazine-2-acetic acid compound, method for production thereof and use thereof
JP2003508391A (ja) 1999-08-31 2003-03-04 マキシア・ファーマシューティカルズ・インコーポレイテッド ベンジリデン−チアゾリジンジオン類およびアナログ類ならびに糖尿病の治療におけるその使用
EP1377559A4 (en) * 2001-03-08 2005-09-28 Incyte San Diego Inc MOLECULES ACTIVATING AN RXR RECEPTOR
US7102000B2 (en) * 2002-03-08 2006-09-05 Incyte San Diego Inc. Heterocyclic amide derivatives for the treatment of diabetes and other diseases
CA2493843C (en) 2002-07-10 2012-04-17 Applied Research Systems Ars Holding N.V. Azolidinone-vinyl fused-benzene derivatives
BR0316386A (pt) * 2002-12-06 2005-09-27 Warner Lambert Co Benzoxazin-3-onas e seus derivados como inibidores de p13k
JP3906471B1 (ja) * 2004-09-28 2007-04-18 大塚製薬株式会社 カルボスチリル化合物
CN100455573C (zh) * 2005-11-11 2009-01-28 华东理工大学 一种制备1,4-苯并噁唑嗪-3-酮化合物的微波合成方法
MX2015010935A (es) * 2013-02-22 2015-10-29 Merck Sharp & Dohme Compuestos biciclicos antidiabeticos.
EP3177287B1 (en) * 2014-08-08 2022-02-23 Merck Sharp & Dohme Corp. Antidiabetic bicyclic compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5522636A (en) * 1978-08-04 1980-02-18 Takeda Chem Ind Ltd Thiazoliding derivative
US4619687A (en) * 1984-09-27 1986-10-28 Sumitomo Chemical Company, Limited Triazolopyridazines and their use as herbicides
CN1003445B (zh) * 1984-10-03 1989-03-01 武田药品工业株式会社 噻唑烷二酮衍生物,其制备方法和用途
HU210339B (en) * 1985-05-21 1995-03-28 Pfizer Process for preparing thiazolidinediones and their pharmaceutical compositions haring hypoglycemic effect
JPH06779B2 (ja) * 1985-06-10 1994-01-05 武田薬品工業株式会社 チアゾリジオン誘導体およびそれを含んでなる医薬組成物
JPS6314782A (ja) * 1986-07-07 1988-01-21 Nippon Tokushu Noyaku Seizo Kk 新規ジアルキルマレインイミド類及び除草剤
US4734124A (en) * 1987-01-15 1988-03-29 Fmc Corporation Tetrazolinone herbicides
FI91869C (fi) * 1987-03-18 1994-08-25 Tanabe Seiyaku Co Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi

Also Published As

Publication number Publication date
DE3864707D1 (de) 1991-10-17
ES2038710T3 (es) 1993-08-01
IE880772L (en) 1988-09-18
HU211596A9 (en) 1995-12-28
FI881104A0 (fi) 1988-03-09
AU1317688A (en) 1988-09-22
HUT50337A (en) 1990-01-29
FI91870B (fi) 1994-05-13
FR2612517B1 (fr) 1992-11-13
DK147588A (da) 1988-09-19
CN1019911C (zh) 1993-02-17
HU203548B (en) 1991-08-28
KR940003071B1 (ko) 1994-04-13
ATE67199T1 (de) 1991-09-15
CN88101541A (zh) 1988-10-05
JPS63230689A (ja) 1988-09-27
AU601029B2 (en) 1990-08-30
GR3002692T3 (en) 1993-01-25
IE60522B1 (en) 1994-07-27
IL85768A (en) 1993-02-21
IL85768A0 (en) 1988-09-30
FR2612517A1 (fr) 1988-09-23
FI91870C (fi) 1994-08-25
DK147588D0 (da) 1988-03-17
EP0283036B1 (en) 1991-09-11
JPH0460597B2 (fi) 1992-09-28
EP0283036A1 (en) 1988-09-21
KR880011154A (ko) 1988-10-26
US4824833A (en) 1989-04-25
CA1305706C (en) 1992-07-28

Similar Documents

Publication Publication Date Title
FI881103A7 (fi) Menetelmä antidiabeettisena aineena käytettävien bensoksatsolijohdannaisten valmistamiseksi
PT88596A (pt) Process for preparing 2-anilinopyrimidine derivatives useful aspesticidas
FI890652A7 (fi) Menetelmä terapeuttisesti aktiivisten substituoitujen indolyylipyrrolijohdannaisten valmistamiseksi
FI905941A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten 2-asyyliaminotiatsolijohdannaisten valmistamiseksi
PT86866A (pt) Process for preparing piperazinyl-heterocyclic compounds
FI885409A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten pyridatsiiniamiinijohdannaisten valmistamiseksi
NO176759C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater
FI906438L (fi) Menetelmä uusien, terapeuttisesti käyttökelpoisten A-nor-steroidi-3-karboksyylihappojohdannaisten valmistamiseksi
FI873069A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten difenyylipropyyliamiinijohdannaisten valmistamiseksi
FI873350A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,4-dihydropyridiinijohdannaisten valmistamiseksi
PT87717A (pt) Process for preparing 2,4-thiazolidinedione derivatives
FI903752A7 (fi) Menetelmä 1,2,3,4-tetrahydro-9-akridiiniamiinin johdannaisten valmistamiseksi
FI893701L (fi) Menetelmä antipsykoottisten 3-piperatsinyylibentsatsolijohdannaisten valmistamiseksi
FI881104L (fi) Menetelmä antidiabeettisina aineina käytettävien bentsoksatsiinijohdannaisten valmistamiseksi
FI883672A7 (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
ES508025A0 (es) "procedimiento para preparar derivados de dihidropiridina".
FI881525A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten N-aryylipiperatsiiniasetamidijohdannaisten valmistamiseksi
FI885838A7 (fi) Menetelmä tioformamidijohdannaisten valmistamiseksi
FI884660L (fi) Menetelmä terapeuttisesti aktiivisten 2,2-dimetyylikromeenijohdannaisten valmistamiseksi
FI891677L (fi) Menetelmä 4-demetoksidaunomysinonin valmistamiseksi
FI885560A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten bisfenyylialkyylipiperatsiinijohdannaisten valmistamiseksi
FI893003L (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI895983A0 (fi) Menetelmä lääkeaineina käyttökelpoisten 2-bentsotiatsoliinijohdannaisten valmistamiseksi
FI892946A7 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten 2,3,4,5-tetrahydro-1H-3-bentsoatsepiinijohdannaisten valmistamiseksi

Legal Events

Date Code Title Description
BB Publication of examined application
MM Patent lapsed

Owner name: TANABE SEIYAKU CO., . LTD.